Effect of pharmacological suppression of secondary hyperparathyroidism on cardiovascular hemodynamics in predialysis CKD patients: A preliminary observation

Hemodialysis International

Volumn 11, Issue 4, 2007, Pages 417-423

  Singh, Narinder P ^a,d   Sahni, Vaibhav ^b   Garg, Dheeraj ^c   Nair, Mohan ^a  

^a G B PANT HOSPITAL   (India)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^d NONE   (India)

Author keywords

Cardiovascular complications; CKD; Diastolic dysfunction; Secondary hyperparathyroidism

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCITRIOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PARATHYROID HORMONE; PLACEBO;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE SIZE; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; MALE; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL; SECONDARY HYPERPARATHYROIDISM; SYSTOLIC DYSFUNCTION;

ADMINISTRATION, ORAL; ADULT; AGED; BLOOD PRESSURE; CALCITRIOL; CARDIOVASCULAR DISEASES; CEREBROVASCULAR CIRCULATION; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; FEMALE; HEMODYNAMICS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PLACEBOS; RENAL DIALYSIS; VENTRICULAR FUNCTION, LEFT;

EID: 35148827540     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2007.00211.x     Document Type: Article

References (36)

1. Wanic-Kossowska M, Lehmann P, Czekalski S. Left ventricular systolic and diastolic dysfunction in patients with chronic renal failure treated with hemodialysis. Pol Arch Med Wewn. 2003; 109: 365-373.
2. Wing AJ, Brunner FP, Brynger H, et al. Cardiovascular related causes of deaths and the fate of patients with renovascular disease. Contrib Nephrol. 1984; 41: 306-311.
3. Drueke T, Fauchet M, Fleury J, et al. Effect of parathyroidectomy on left ventricular function in hemodialysis patients. Lancet. 1980; 1: 112-114.
4. Nasri H, Baradaran A, Naderi AS. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Acta Med Austriaca. 2004; 31: 67-72.
5. 3 stimulates calcium uptake by cultured adult rat ventricular cardiac muscle cells. J Biol Chem. 1987; 262: 2536-2541.
6. 3 receptors identified in rat heart. J Mol Cell Cardiol. 1986; 18: 67-72.
7. Baczynski R, Massry SG, Kohan R, Magott M, Saglikes Y, Brautbar N. Effect of PTH on myocardial energy metabolism in rat. Kidney Int. 1985; 27: 718-725.
8. El-Belbessi S, Brautbar N, Anderson K, Campese VM, Massry SG. Effect of CRF on heart, role of SHPT. Am J Nephrol. 1986; 6: 369-375.
9. Zyang YB, Smogorzewski M, Ni Z, Massry SG. Altered cytosolic calcium homeostasis in rat cardiac myocytes in ESRF. Kidney Int. 1994; 45: 1113-1119.
10. Schluter KD, Piper HM. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res. 1998; 37: 34-41.
11. Saleh FN, Schirmer H, Sundsfjord J, Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J. 2003; 24: 2054-2060.
12. Katoh Y, Klein KL, Kaplan A. Parathyroid hormone has a positive inotropic action in the rat. Endocrinology. 1981; 109: 2252-2254.
13. Hara S, Ubara Y, Arizono K, et al. Relation between parathyroid hormone and cardiac function in long-term hemodialysis patients. Miner Electrolyte Metab. 1995; 21: 72-76.
14. McGonigle R, Fowler M, Weston M, Parsons V. Uremic cardiomyopathy: Potential role of vitamin D and parathyroid hormone. Nephron. 1984; 36: 94-100.
15. Sato S, Ohta M, Kawaguchi Y, et al. Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism. Miner Electrolyte Metab. 1995; 21: 67-71.
16. Nappi S, Saha H, Virtanen V, et al. Left ventricular structure and function in primary hyperparathyroidism before and after parathyroidectomy. Cardiology. 2000; 93: 229-233.
17. Rostand SG, Sanders PC, Rutsky EA. Cardiac calcification in uraemia. Contrib Nephrol. 1994; 106: 26-29.
18. Ohara N, Hiramitsu K, Shigematsu S, et al. Effects of parathyroid hormone on left ventricular function in patients with primary hyperparathyroidism. Miner Electrolyte Metab. 1995; 21: 63-66.
19. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. NEJM. 2004; 351: 1296-1205.
20. Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial. 2003; 16: 101-105.
21. Brickman AS, Coburn JW, Norman AW. Action of calcitriol, a potent kidney-produced metabolite of vitamin-D3, in uraemic man. NEJM. 1972; 287: 891-895.
22. Berl T, Berns AS, Hufer WE, et al. Effect of calcitriol in chronic dialysis patients: A double-blind controlled study. Ann Intern Med. 1978; 88: 774-781.
23. Lemmila S, Saha H, Virtanen V, Ala-Houhala I, Pasternack A. Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis. Am J Nephrol. 1998; 18: 404-410.
24. Parfrey PS, Harnett JD, Gault HM, Barre PE, Guttman RD. Low-output left ventricular failure in end-stage renal diseases. Am J Nephrol. 1987; 7: 184-191.
25. Parfrey PS, Harnett JD, Griffiths S, Gault HM, Barre PE. Congestive heart failure in dialysis patients. Arch Intern Med. 1988; 148: 1519-1525.
26. 3. Contrib Nephrol. 1984; 41: 433-437.
27. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parafrey PS. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int. 1995; 47: 884-890.
28. Mall G, Rambausek M, Neumeister A, Kollmar S, Vetterlein F, Ritz E. Myocardial interstitial fibrosis in experimental uraemia: Implications for cardiac compliance. Kidney Int. 1988; 33: 804-811.
29. Harnett JD, Parfrey PS, Gault MH, Barre P, Guttmann RD. Left ventricular hypertrophy in ESRD. Nephron. 1988; 48: 107-115.
30. Rostand SG, Sanders C, Kirk KA, Rutsky EA, Fraser RG. Myocardial calcification and cardiac dysfunction in CRF. Am J Med. 1988; 85: 651-657.
31. Goto N, Tominaga Y, Matsuoka S, et al. Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients: Special focus on dilated cardiomyopathy. Clin Exp Nephrol. 2005; 9: 138-141.
32. Ruuffman K, Mandelbaum A, Bommer J, Schmidli M, Ritz E. Doppler echocardiographic findings in dialysis patients. Nephrol Dial Transplant. 1990; 5: 426-431.
33. Huting J, Kramer W, Reitinger J, Kuhn K, Schutterle G, Wizemann V. Abnormal diastolic left ventricular filling by pulse Doppler echocardiography in patients on continous ambulatory peritoneal dialysis. Clin Nephrol. 1991; 36: 21-28.
34. Facchin L, Vescovo G, Levedianos G, et al. Left ventricular morphology and diastolic function in uraemia: Echocardiacographic evidence of a specific cardiomyopathy. Br Heart J. 1995; 74: 174-179.
35. Almqvist EG, Bondeson AG, Bondeson L, Nissborg A, Smedgard P, Svensson SE. Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery. 2002; 132: 1126-1132.
36. Nilsson IL, Aberg J, Rastad J, Lind L. Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism. Surgery. 2005; 137: 632-638.